Our vision
Moving diagnostic frontiers in dermatology.
Our mission
We build leading innovative molecular diagnostic solutions at scale and at point of need for diagnostic laboratories, dermatologists and academic and pharmaceutical research organizations. With our quick, precise and automated tests, we enable skin experts to recommend the best treatments for human skin health.
Company history
Dermagnostix was founded as a spin-off from the Hahn-Schickard Institut in Freiburg, the Helmholtz Zentrum München (HMGU) and TU Munich, after decades of top-level research in dermatology, immunology, bioinformatics and microfluidics. We are located in Southern Germany (Freiburg).
Game-changing modern therapies have evolved the treatment of inflammatory disease and skin cancer. Diagnostics have not kept pace with these therapeutic advances. Dermagnostix closes this gap bringing objective molecular results directly to the physician.
CEO and board
Professor and Chair in Dermatology, Co-founder of Dermagnostix.
Friedrich Hecker
Non-Executive Board Member, Senior Advisor, Startup Investor.
Martin Klässner
Serial Entrepreneur and Investor with Software-as-a-Service background in the domains Energy, Medical and Robotics.
Prof. Helmut Laaff, MD
Dermatopathologist, Owner IDPM Freiburg Group, Professor Department Chemistry and Pharmacy University Freiburg.
Translational Research Inflammatory Skin Diseases, University Medical Center Hamburg; Medical Director JeruCON GmbH.
Prof. Roland Zengerle, PhD
Professor for MEMS applications, University of Freiburg; Executive Board member of Hahn-Schickard.
Scientific advisors
Prof. Stefanie Eyerich, PhD
Professor for Functional Allergology and Co-Founder of Dermagnostix.
Prof. Christoffer Gebhardt, MD
Professor for Dermato-Oncology and Co-Founder of Dermagnostix.
Michael Howell, PhD
Immunologist, Biotech Entrepreneur, Translational Science and Biomarker Leader in Oncology, Inflammation and Immunology.
Nils Paust, PhD
Microfluidics Engineer, Associate Director of the Hahn-Schickard Institute of Microanalysis Systems and Co-Founder of Dermagnostix.
Prof. Fabian Theis, PhD, PhD
Mathematician, Physicist, Pioneer in Biomedical AI and Machine Learning and Co-Founder of Dermagnostix.
Management
„Jeder einzelne Mensch bei Dermagnostix lebt Qualität, deshalb werden wir den Markt nachhaltig gestalten und verändern.“
“Dermagnostix not only provides objective molecular results at the point of need, but it also enables broad molecular laboratory efficiencies.”
"Our products are the results of many years of scientific work in the fields of dermatological research and innovative microfluidic technologies."
"Dermatology urgently needs objective and feasible molecular diagnostics to enable precision medicine for our patients."
“I am proud to lead a team that is fueled by a genuine passion for technology and a relentless pursuit of quality, all with our customers at the forefront of our minds.”
"High quality in production is what brings visions to life. And that's what drives me at Dermagnostix."
"I am proud to be part of Dermagnostix to help patients suffering from skin diseases receive accurate diagnoses and treatment."
"The interdisciplinary team provides the expertise to bring together platform, assay and microfluidic test cartridge."
"Systems integration combines all modern disciplines of life science, microsystems technologies and engineering for the product development of Dermagnostix."
Team
“With data science, we have the power to turn information into insight, complexity into clarity, and challenges into opportunities.”
"Through save and stable production processes I want to ensure that innovative and high-quality products permanently move Dermagnostix forward."
“Dermagnostix creates the perfect synergy between cutting-edge research and the technical implementation in product development, fostering an ideal environment for my professional and personal growth.”
"The most challenging task at Dermagnostix for me was to come up with a smart quote - and it still sounds pathetic…"
"Constantly improving our innovative technology to shape the future of skin disease diagnostics and improve patients' lives make me proud to be part of the Dermagnostix team."
“Guaranteeing high quality products to make a meaningful difference for patients is our mission and I am proud to be part of it.”
"Developing diagnostic products means improving patients' lives as treatments can be selected precisely. This is what motivates me and makes me happy to be part of the team."
"Excellent customer service is essential for satisfied customers. Therefore it is my daily motivation to move Dermagnostix forward together with a strong team, always with an eye on customer needs."
"I love the ideas behind our products: At Dermagnostix, development really means to make success visible and to create value for the patients."
"Working in a visionary team inspires me to contribute my best to keep Dermagnostix thriving."
"I am driven by the belief that patient treatment can be improved through ensuring high quality of our products."
"Dermagnostix makes me feel good in my skin."
"Innovative minds, cutting-edge technology and a clear commitment to enhance patients' health steer our efforts to pioneer the future of skin diagnostics."
“The combination of molecular diagnostics with modern microfluidic technology is an area with a strong future. Dermagnostix continues to grow this area and I like to be a part of it.“
"Good work makes you feel good, especially good work makes you feel especially good. Success is inseparably connected with a feeling of satisfaction."
“The innovative and visionary mindset of Dermagnostix and the entire team is the driving force behind our strong brand.”
Dermagnostix, a spin-off company of
By loading the video, you agree to YouTube's privacy policy.
Learn more
Awards
2023
2022
2022
2021
2020
2020
2020
2020
2020
2020
2019
2018
Certification
Since November 2022 Dermagnostix is officially EN ISO 13485 certified
view certificate
Member of
